MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 185 filers reported holding MANNKIND CORP in Q2 2022. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,170,000 | +0.4% | 9,000,000 | -1.1% | 0.58% | +15.5% |
| Q2 2023 | $37,037,000 | -0.7% | 9,100,000 | 0.0% | 0.50% | -9.2% |
| Q1 2023 | $37,310,000 | -22.2% | 9,100,000 | 0.0% | 0.55% | -22.9% |
| Q4 2022 | $47,957,000 | +70.6% | 9,100,000 | 0.0% | 0.72% | +38.2% |
| Q3 2022 | $28,119,000 | -18.9% | 9,100,000 | 0.0% | 0.52% | -24.2% |
| Q2 2022 | $34,671,000 | +7.1% | 9,100,000 | +3.4% | 0.68% | +15.9% |
| Q1 2022 | $32,384,000 | -15.8% | 8,800,000 | 0.0% | 0.59% | -9.6% |
| Q4 2021 | $38,456,000 | +0.5% | 8,800,000 | 0.0% | 0.65% | +8.8% |
| Q3 2021 | $38,280,000 | -18.6% | 8,800,000 | +2.0% | 0.60% | -26.5% |
| Q2 2021 | $47,034,000 | +60.0% | 8,630,000 | +15.1% | 0.82% | +61.0% |
| Q1 2021 | $29,400,000 | +168.4% | 7,500,000 | +114.3% | 0.51% | +168.8% |
| Q4 2020 | $10,955,000 | – | 3,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 557,051 | $2,050,000 | 1.09% |
| 180 WEALTH ADVISORS, LLC | 1,369,904 | $4,877,000 | 1.06% |
| EMERALD ADVISERS, LLC | 5,675,539 | $20,886,000 | 0.80% |
| DG Capital Management, LLC | 1,035,693 | $3,811,000 | 0.76% |
| Parkman Healthcare Partners LLC | 675,403 | $2,485,000 | 0.73% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 4,358,087 | $16,038,000 | 0.71% |
| Avoro Capital Advisors LLC | 8,800,000 | $32,384,000 | 0.59% |
| Monarch Partners Asset Management LLC | 420,478 | $1,547,000 | 0.35% |
| Bruce & Co., Inc. | 395,073 | $1,453,000 | 0.30% |
| SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,557,000 | 0.23% |